Incyte (($INCY)) announced an update on their ongoing clinical study. Incyte Corporation is currently conducting a clinical study titled ‘An ...

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The global oncology market is rapidly shifting ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has launched a Phase 1 clinical study titled ‘AN ...

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring ...

CU Anschutz pharmaceutical researchers use stem cells to mimic infant liver cells in testing drug safety and efficacyA new ...

Syngene International invests in peptide lab in Bengaluru and advanced automation in Hyderabad to enhance research efficiency ...

India: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced ...

In the rapidly evolving pharmaceutical landscape, drug discovery services have become a pivotal axis around which innovation, efficiency and competitiveness rotate. According to a recent market report ...

Syngene International invests in dedicated peptide lab and advanced automation in Bengaluru & Hyderabad: Our Bureau, Bengaluru Wednesday, October 15, 2025, 17:30 Hrs [IST] Syngene ...

The polyamines are present in virtually all cells, prokaryotic or eukaryotic. Their biosynthesis and metabolism are highly regulated and unique active cellular transporters exist. They are known to be ...

Novel targeted therapies for ARID1A-mutant and CDA-resistant cancers highlighted MENLO PARK, CA / ACCESS Newswire / October 27, 2025 / Edison Oncology, a clinical-stage biopharmaceutical company ...